These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 20929509)
21. Serum retinol-binding protein 4 is elevated and positively associated with insulin resistance in postmenopausal women. An C; Wang H; Liu X; Li Y; Su Y; Gao X; Jiang W Endocr J; 2009; 56(8):987-96. PubMed ID: 19671994 [TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159 [TBL] [Abstract][Full Text] [Related]
23. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus]. Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259 [TBL] [Abstract][Full Text] [Related]
24. Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population. Xu M; Li XY; Wang JG; Wang XJ; Huang Y; Cheng Q; Huang HE; Li R; Xiang J; Tan JR; Dai M; Ning G Diabetologia; 2009 Aug; 52(8):1511-9. PubMed ID: 19506831 [TBL] [Abstract][Full Text] [Related]
25. Retinol binding protein-4 predicts incident diabetes in Asian Indian men with prediabetes. Ram J; Snehalatha C; Selvam S; Nanditha A; Shetty AS; Godsland IF; Johnston DG; Ramachandran A Biofactors; 2015 May; 41(3):160-5. PubMed ID: 25810022 [TBL] [Abstract][Full Text] [Related]
26. Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Weiping L; Qingfeng C; Shikun M; Xiurong L; Hua Q; Xiaoshu B; Suhua Z; Qifu L Endocrine; 2006 Dec; 30(3):283-7. PubMed ID: 17526940 [TBL] [Abstract][Full Text] [Related]
27. Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance. Liu F; Qu H; Li Y; Tang Q; Yang Z; Wang H; Deng H Endocr J; 2015; 62(8):733-40. PubMed ID: 26041556 [TBL] [Abstract][Full Text] [Related]
28. Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population. Hu C; Jia W; Zhang R; Wang C; Lu J; Wu H; Fang Q; Ma X; Xiang K Diabet Med; 2008 Jan; 25(1):11-8. PubMed ID: 18199128 [TBL] [Abstract][Full Text] [Related]
29. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Klöting N; Graham TE; Berndt J; Kralisch S; Kovacs P; Wason CJ; Fasshauer M; Schön MR; Stumvoll M; Blüher M; Kahn BB Cell Metab; 2007 Jul; 6(1):79-87. PubMed ID: 17618858 [TBL] [Abstract][Full Text] [Related]
30. Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus. Vergès B; Guiu B; Cercueil JP; Duvillard L; Robin I; Buffier P; Bouillet B; Aho S; Brindisi MC; Petit JM Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3050-7. PubMed ID: 23087360 [TBL] [Abstract][Full Text] [Related]
31. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study. Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208 [TBL] [Abstract][Full Text] [Related]
33. Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Nagaretani H; Nakamura T; Funahashi T; Kotani K; Miyanaga M; Tokunaga K; Takahashi M; Nishizawa H; Kishida K; Kuriyama H; Hotta K; Yamashita S; Matsuzawa Y Diabetes Care; 2001 Dec; 24(12):2127-33. PubMed ID: 11723095 [TBL] [Abstract][Full Text] [Related]
34. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236 [TBL] [Abstract][Full Text] [Related]
35. Association between transthyretin concentrations and gestational diabetes mellitus in Chinese women. Liu M; Chen Y; Chen D Arch Gynecol Obstet; 2020 Aug; 302(2):329-335. PubMed ID: 32451658 [TBL] [Abstract][Full Text] [Related]
36. Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study. Gastaldelli A; Gaggini M; DeFronzo RA Diabetes; 2017 Apr; 66(4):815-822. PubMed ID: 28052966 [TBL] [Abstract][Full Text] [Related]
37. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Abdul-Ghani MA; Williams K; DeFronzo R; Stern M Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587 [TBL] [Abstract][Full Text] [Related]
38. Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study. Chang X; Yan H; Bian H; Xia M; Zhang L; Gao J; Gao X Lipids Health Dis; 2015 Apr; 14():28. PubMed ID: 25890223 [TBL] [Abstract][Full Text] [Related]
39. Insulin sensitivity and secretion in youth onset type 2 diabetes with and without visceral adiposity. Amutha A; Ali MK; Unnikrishnan R; Anjana RM; Ranjani H; Gokulakrishnan K; Mohan V; Narayan KM Diabetes Res Clin Pract; 2015 Jul; 109(1):32-9. PubMed ID: 26008722 [TBL] [Abstract][Full Text] [Related]
40. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Möhlig M; Weickert MO; Ghadamgahi E; Arafat AM; Spranger J; Pfeiffer AF; Schöfl C Eur J Endocrinol; 2008 Apr; 158(4):517-23. PubMed ID: 18362299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]